Acute interstitial nephritis related to lansoprazole administration. 2008

Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
Dcpartmcnt of Clinical Pharmacy, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.

Acute interstitial nephritis (AIN) is a rare but serious adverse effect reported with proton pump inhibitors (PPIs). Only one report (2 cases) of AIN with lansoprazole is published in literature. A case of lansoprazole induced interstitial nephritis (biopsy supported) was reported in an elderly female patient admitted to the hospital with non specific symptoms after 45 days of treatment with the drug. A recovery was noticed upon withdrawal of the drug and treatment with corticosteroids. We consider this report as a valuable addition to the existing literature on this rare adverse effect with lansoprazole. This potentially serious adverse effect with PPIs including lansoprazole has to be given due consideration, especially taking into account the wide spread use of this group of agents.

UI MeSH Term Description Entries
D009395 Nephritis, Interstitial Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction. Interstitial Nephritis,Nephritis, Tubulointerstitial,Tubulointerstitial Nephritis,Interstitial Nephritides,Nephritides, Interstitial,Nephritides, Tubulointerstitial,Tubulointerstitial Nephritides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D053799 2-Pyridinylmethylsulfinylbenzimidazoles Compounds that contain benzimidazole joined to a 2-methylpyridine via a sulfoxide linkage. Several of the compounds in this class are ANTI-ULCER AGENTS that act by inhibiting the POTASSIUM HYDROGEN ATPASE found in the PROTON PUMP of GASTRIC PARIETAL CELLS. 2-Methylpyridine 2-Benzimidazole Sulfoxides,2-Pyridinylmethylsulfinyl-2-Benzimidazoles,Benzimidazole Methylpyridine Sulfoxides,Timoprazole Derivatives,Timoprazoles,2 Methylpyridine 2 Benzimidazole Sulfoxides,2 Pyridinylmethylsulfinyl 2 Benzimidazoles,2 Pyridinylmethylsulfinylbenzimidazoles,2-Benzimidazole Sulfoxides, 2-Methylpyridine,Methylpyridine Sulfoxides, Benzimidazole,Sulfoxides, 2-Methylpyridine 2-Benzimidazole,Sulfoxides, Benzimidazole Methylpyridine
D064747 Lansoprazole A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers. Lansoprazoles,2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole,AG 1749,AG-1749,Agopton,Bamalite,Lansol,Lansoprazol,Lansoprazole Sodium,Lanzor,Monolitum,Ogast,Ogastro,Opiren,Prevacid,Prezal,Pro Ulco,Promeco,Takepron,Ulpax,Zoton,AG1749,Sodium, Lansoprazole

Related Publications

Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
March 2009, Southern medical journal,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
October 1980, Gastroenterology,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
January 1998, The Annals of pharmacotherapy,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
October 2022, Postgraduate medical journal,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
December 2016, British journal of cancer,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
July 1976, Antimicrobial agents and chemotherapy,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
December 2012, International urology and nephrology,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
April 2013, Current drug safety,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
June 2010, Kidney international,
Jimmy Jose, and Kavitha Saravu, and Kanav Khera, and Beena Jimmy, and Barkur Anantha Krishna Shastry
May 1898, Journal. Boston Society of Medical Sciences,
Copied contents to your clipboard!